Loading...
•
Mar 31, 2020
Harrow Q1 2020 Earnings Report
Reported results for the first quarter 2020.
Key Takeaways
Harrow Health reported its first quarter 2020 results, with management expressing excitement about the ImprimisRx team's role in providing for physician customers and improving health outcomes as the economy reopens.
Harrow Health published its first quarter 2020 letter to stockholders.
CEO Mark L. Baum is excited about the ImprimisRx team getting back to being a trusted provider to physician customers.
The company is starting to see orders come in as customers re-open.
Harrow Health is excited about upcoming events, catalysts, and developments in the near and long-term.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...